| Tag | Content |
|---|
EnhancerAtlas ID | HS162-00720 |
Organism | Homo sapiens |
Tissue/cell | Plasma_cell_myeloma |
Coordinate | chr1:161581650-161582870 |
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| EWSR1-FLI1 | MA0149.1 | chr1:161582764-161582782 | CCTCCCTTCCTTCCTTTG | - | 6.66 | | EWSR1-FLI1 | MA0149.1 | chr1:161582760-161582778 | CTTTCCTCCCTTCCTTCC | - | 9.01 | | KLF5 | MA0599.1 | chr1:161582351-161582361 | GGGGCGGGGC | - | 6.02 | | ZNF263 | MA0528.1 | chr1:161582760-161582781 | CTTTCCTCCCTTCCTTCCTTT | - | 6.12 | | ZNF263 | MA0528.1 | chr1:161582205-161582226 | TGAGGAGTGCGGGGGGGAAGA | + | 6.2 |
|
| | Number of super-enhancer constituents: 15 | ID | Coordinate | Tissue/cell |
| SE_07357 | chr1:161580788-161584698 | Brain_Hippocampus_Middle_150 | | SE_09867 | chr1:161579384-161583530 | CD14 | | SE_12235 | chr1:161581303-161583400 | CD3 | | SE_12654 | chr1:161581792-161582273 | CD34_adult | | SE_12771 | chr1:161581697-161581833 | CD34_fetal | | SE_12771 | chr1:161581912-161582301 | CD34_fetal | | SE_12771 | chr1:161582578-161582932 | CD34_fetal | | SE_13494 | chr1:161579645-161584358 | CD34_Primary_RO01536 | | SE_15335 | chr1:161579226-161584686 | CD4_Memory_Primary_7pool | | SE_16693 | chr1:161581295-161583416 | CD4_Naive_Primary_8pool | | SE_20036 | chr1:161580924-161584169 | CD56 | | SE_20740 | chr1:161577990-161584457 | CD8_Memory_7pool | | SE_22436 | chr1:161580812-161584433 | CD8_primiary | | SE_39938 | chr1:161580902-161584380 | K562 | | SE_53727 | chr1:161580858-161583334 | Spleen |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 2 | Chromosome | Start | End |
| chr1 | 161582451 | 161582780 | | chr1 | 161582212 | 161582506 |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH01I161611 | chr1 | 161580791 | 161583390 |
|
Enhancer Sequence | GATCGAAAAG TCTTTCTCTA AGAATTCAAA CATAATTGCT GGTTGGTTCA AATCAGGAGG 60
AAAAGTAAGG ATGGAAAACA TACGTTGTCA AAAGTGGGAT TCGAACCCAC GCCTCCAGCG 120
GAGGGTGCGA TTTGAACGCA GCGCCTTAAG ACTGCTCGGC CATCCTGACA CACGTTTTGC 180
TAAACTTCCT AATTTCTCCT AATTTTATCA TATACTGATG GTGCACGCTA TCAGGTCACA 240
TTAATGTGTC TATTTACTGT TTCAAATAAA ATTGTAACTC TCTCTAGACC TTGTCGCAAA 300
GCGGGAAAAA TGAAACAGCC TCCGACAGCT CTTTCCTCTT TCCTCACTAC CCAAACTAAA 360
CCTTAAGGCT CCATTTTCCC TGGCGACTCT TCGAGCGCCC CTCTGCTTCT GTAGAGGGGT 420
CGAGCCATGT CAAGGTAGAC CCTGTGTCGG CCCGTCTCCC TCGGATCCTC CGCACCAATC 480
ACTGTTGCTG AATCCGACAC CCGGCGGATC CAGTGCGGAG TCTCGAACAG CTGCGGAGCT 540
GGGAGCTACG GGACATGAGG AGTGCGGGGG GGAAGAGAAG ACGGCGGAGG AAAATCCCCC 600
GGCGGTGCTC AACTGCGGCT TTCTCTCTCG GCTGTGAGCC GGCTCCGCCC TCCGGCTTCC 660
AGAGCAAGTG GCTTCTGCGT TCACCGCCCC CCGCCGTTTG TGGGGCGGGG CCGATTCATA 720
AGAATCGGTT CTCACCAATG GAGGGCTTAG CATGTTTAAC CTCAGGATCA TAAACAAAAG 780
ACACTGCTAG AACGGTCGGG AAAGTCATAC GCTTTGCTTA TCTTATATAT AGATTTCTAA 840
AATTCCAAAC CGGGGACGCG TTGGTGGTGT AGTGGTGAGC ACAGCTGCCT TTCAAGCAGT 900
TAACGCGGGT TCGATTCCCG GGTAACGAAA CGTTTTTGTC TTTCCTTCTA CGAAAAACTT 960
TTCTGAGCCG GAGCCTCCAG CGCGCTGTGT ATTCGTTTTA CGCCTCAACG AAACTGCAGC 1020
AATACCTCAC TTTCCGTACT CGCTTCCTGT CTTTCCCCTG GCCTCTTTCT AAACCCAGGC 1080
TTTTTTTGAA GGGATTAAAT TCTGATGGTT CTTTCCTCCC TTCCTTCCTT TGTAAACTTC 1140
CAACTCTTGA GGAATCTTTG GGATCATTTC AATCCTGGGA TGAGTCTTAG CTTCAGAAAG 1200
GGGCTCTTGT GTCTTCACTT 1220
|
